SOPHiA GENETICS (SOPH) Net Income towards Common Stockholders (2020 - 2025)

SOPHiA GENETICS's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$20.0 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders fell 43.39% year-over-year to -$20.0 million; the TTM figure through Dec 2025 stood at -$76.0 million (down 26.53% YoY), while the FY2025 annual figure was -$76.0 million, down 26.53% from the prior year.
• Net Income towards Common Stockholders came in at -$20.0 million for Q4 2025 at SOPHiA GENETICS, down from -$18.7 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$12.3 million in Q1 2021 to a low of -$25.0 million in Q1 2022.
• A 5-year average of -$18.8 million and a median of -$19.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 99.81% in 2021 and sank 103.13% in 2022, its largest moves.
• SOPHiA GENETICS's Net Income towards Common Stockholders stood at -$22.4 million in 2021, then surged by 35.4% to -$14.5 million in 2022, then tumbled by 66.1% to -$24.1 million in 2023, then surged by 42.12% to -$13.9 million in 2024, then tumbled by 43.39% to -$20.0 million in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$20.0 million, -$18.7 million, and -$20.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison